Dublin (IE), 11th September 2019: Inflazome (inflazome.com), the pioneering, clinical stage, inflammasome biotech company developing multiple small molecule drugs that inhibit harmful inflammation, is pleased to announce that our CSO, Prof. Luke O'Neill has been listed as one of the world’s most cited scientists by a new citation metrics database. The database systematically and objectively ranks 100,000 of the globe’s most cited scientists based on their research output.
Compiled by an independent team of researchers and recently published in leading international journal PLOS Biology, the database has ranked Prof. O'Neill 477th globally, and notably as Ireland’s most cited scientist. Prof. O'Neill is recognised as a global pioneer in inflammation and immunology research and has been involved with Inflazome since its inception in 2016, both as a co-founder and Chief Scientific Officer.
Read the full article